Cite
HARVARD Citation
Tacken, P. et al. (n.d.). 820 MCLA-145 is a bispecific IgG1 antibody that inhibits PD-1/PD-L1 signaling while simultaneously activating CD137 signaling on T cells. Journal for immunotherapy of cancer. p. A870. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Tacken, P. et al. (n.d.). 820 MCLA-145 is a bispecific IgG1 antibody that inhibits PD-1/PD-L1 signaling while simultaneously activating CD137 signaling on T cells. Journal for immunotherapy of cancer. p. A870. [Online].